首页> 外文期刊>Antimicrobial agents and chemotherapy. >Comparative in vitro activities of ciprofloxacin, clinafloxacin, gatifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter cloacae, and Enterobacter aerogenes clinical isolates with al
【24h】

Comparative in vitro activities of ciprofloxacin, clinafloxacin, gatifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter cloacae, and Enterobacter aerogenes clinical isolates with al

机译:环丙沙星,克林沙星,加替沙星,左氧氟沙星,莫西沙星和曲伐沙星对肺炎克雷伯菌,产氧克雷伯菌,阴沟肠杆菌和产气肠杆菌临床分离株的体外活性比较

获取原文
获取原文并翻译 | 示例
       

摘要

The in vitro activities of ciprofloxacin, clinafloxacin, gatifloxacin, levofloxacin, moxifloxacin, and trovafloxacin were tested against 72 ciprofloxacin-resistant and 28 ciprofloxacin-susceptible isolates of Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter cloacae, and Enterobacter aerogenes. Irrespective of the alterations in GyrA and ParC proteins, clinafloxacin exhibited greater activity than all other fluoroquinolones tested against K. pneumoniae and E. aerogenes.
机译:测试了环丙沙星,克林沙星,加替沙星,左氧氟沙星,莫西沙星和曲伐沙星的体外活性对72株耐环丙沙星和28株对环丙沙星敏感的肺炎克雷伯菌,产气肠杆菌和肠杆菌的分离株的活性。不管GyrA和ParC蛋白的变化如何,克林沙星都比针对肺炎克雷伯菌和产气链球菌测试的所有其他氟喹诺酮类药物表现出更高的活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号